Effects of Hazelnuts and Cocoa on Metabolic Parameters and Vascular Reactivity
1 other identifier
interventional
61
1 country
1
Brief Summary
This study aims to assess the effects of hazelnuts, cocoa, and the combination of both on vascular reactivity and metabolic profile. Participants, divided in six groups, will receive one of these breakfast integrations for 14 days: group 1) 30 g peeled hazelnuts; group 2) 30 g unpeeled hazelnuts; group 3) snack with 30 g peeled hazelnuts; group 4) snack with 2.5 g cocoa powder; group 5) snack with 30 g peeled hazelnuts and 2.5 g cocoa; group 6) empty snack, control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cardiovascular-diseases
Started Jun 2014
Shorter than P25 for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 21, 2016
CompletedFirst Posted
Study publicly available on registry
July 27, 2016
CompletedSeptember 9, 2016
September 1, 2016
9 months
July 21, 2016
September 7, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effects of a breakfast integration on vascular reactivity, assessed by the variation of peak systolic velocity of the brachial artery, in healthy subjects.
Vascular reactivity is measured by assessing the peak systolic velocity (PSV in cm/s) of the brachial artery at rest and after 3 minutes of arterial occlusion using an echographer in Doppler mode. To occlude arterial inflow, a sphygmomanometric cuff is placed above the antecubital fossa and inflated to at least 50 mmHg above systolic pressure for 3 minutes.
2 weeks
Secondary Outcomes (13)
Effects of a breakfast integration on total cholesterol (mg/dL) in healthy subjects.
2 weeks
Effects of a breakfast integration on high-density lipoprotein-cholesterol (mg/dL) in healthy subjects.
2 weeks
Effects of a breakfast integration on low-density lipoprotein-cholesterol (mg/dL) in healthy subjects.
2 weeks
Effects of a breakfast integration on triglycerides (mg/dL) in healthy subjects.
2 weeks
Effects of a breakfast integration on glucose (mg/dL) in healthy subjects.
2 weeks
- +8 more secondary outcomes
Study Arms (6)
30g peeled hazelnuts cream
EXPERIMENTALEvery person in this group will receive a 30 g peeled hazelnuts cream as an integration to his usual breakfast, and will be asked not to change his diet and physical activity during the 2-week trial.
30g unpeeled hazelnuts cream
EXPERIMENTALEvery person in this group will receive a 30 g unpeeled hazelnuts cream as an integration to his usual breakfast, and will be asked not to change his diet and physical activity during the 2-week trial.
snack w/ 30g peeled hazelnuts
EXPERIMENTALEvery person in this group will receive a snack with 30 g peeled hazelnuts as an integration to his usual breakfast, and will be asked not to change his diet and physical activity during the 2-week trial.
snack w/ 2.5g cocoa powder
EXPERIMENTALEvery person in this group will receive a snack with 2.5 g cocoa powder as an integration to his usual breakfast, and will be asked not to change his diet and physical activity during the 2-week trial.
snack w/ 30g peeled hazelnuts+2.5g cocoa
EXPERIMENTALEvery person in this group will receive a snack with 30 g peeled hazelnuts and 2.5 g cocoa powder as an integration to his usual breakfast, and will be asked not to change his diet and physical activity during the 2-week trial.
empty snack
PLACEBO COMPARATOREvery person in this group will receive an empty snack as an integration to his usual breakfast, and will be asked not to change his diet and physical activity during the 2-week trial.
Interventions
This dietary supplement contains 30 g of hazelnut.
This dietary supplement contains 2.5 g of cocoa powder.
This dietary supplement does not contain hazelnut nor cocoa powder.
This dietary supplement is just a cream obtained by grinding hazelnuts.
This dietary supplement is a commercial snack containing either hazelnut or cocoa or both.
Eligibility Criteria
You may qualify if:
- BMI 18.5-24.9 kg/m2
You may not qualify if:
- diabetes mellitus
- glucose intolerance
- dyslipidemia
- metabolic syndrome
- allergies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ospedale San Donatolead
- Soremartec Italia S.r.l.collaborator
Study Sites (1)
San Donato Hospital
San Donato Milanese, 20097, Italy
Related Publications (4)
Sartori TE, Nunes RA, da Silva GT, da Silva SC, Rondon MU, Negrao CE, Mansur AJ. Influence of demographic and metabolic variables on forearm blood flow and vascular conductance in individuals without overt heart disease. Vasc Health Risk Manag. 2010 Jun 1;6:431-7. doi: 10.2147/vhrm.s10683.
PMID: 20539845RESULTAcree LS, Comp PC, Whitsett TL, Montgomery PS, Nickel KJ, Fjeldstad AS, Fjeldstad C, Gardner AW. The influence of obesity on calf blood flow and vascular reactivity in older adults. Dyn Med. 2007 Mar 26;6:4. doi: 10.1186/1476-5918-6-4.
PMID: 17386093RESULTPapaioannou GI, Seip RL, Grey NJ, Katten D, Taylor A, Inzucchi SE, Young LH, Chyun DA, Davey JA, Wackers FJ, Iskandrian AE, Ratner RE, Robinson EC, Carolan S, Engel S, Heller GV. Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study). Am J Cardiol. 2004 Aug 1;94(3):294-9. doi: 10.1016/j.amjcard.2004.04.022.
PMID: 15276091RESULTChandran DS, Jaryal AK, Jyotsna VP, Deepak KK. Impaired endothelium mediated vascular reactivity in endogenous Cushing's syndrome. Endocr J. 2011;58(9):789-99. doi: 10.1507/endocrj.ej11-0030. Epub 2011 Jul 21.
PMID: 21778615RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
July 21, 2016
First Posted
July 27, 2016
Study Start
June 1, 2014
Primary Completion
March 1, 2015
Study Completion
March 1, 2015
Last Updated
September 9, 2016
Record last verified: 2016-09